132 related articles for article (PubMed ID: 20648397)
1. The role of the thymus in allogeneic hematopoietic stem cell transplantation.
Krenger W; Holländer GA
Swiss Med Wkly; 2010; 140():w13051. PubMed ID: 20648397
[TBL] [Abstract][Full Text] [Related]
2. Thymic T-cell development in allogeneic stem cell transplantation.
Krenger W; Blazar BR; Holländer GA
Blood; 2011 Jun; 117(25):6768-76. PubMed ID: 21427289
[TBL] [Abstract][Full Text] [Related]
3. Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again.
Toubert A; Glauzy S; Douay C; Clave E
Tissue Antigens; 2012 Feb; 79(2):83-9. PubMed ID: 22220718
[TBL] [Abstract][Full Text] [Related]
4. The immunopathology of thymic GVHD.
Krenger W; Holländer GA
Semin Immunopathol; 2008 Dec; 30(4):439-56. PubMed ID: 18974988
[TBL] [Abstract][Full Text] [Related]
5. The thymus in GVHD pathophysiology.
Krenger W; Holländer GA
Best Pract Res Clin Haematol; 2008 Jun; 21(2):119-28. PubMed ID: 18503980
[TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
7. Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease.
Dudakov JA; Mertelsmann AM; O'Connor MH; Jenq RR; Velardi E; Young LF; Smith OM; Boyd RL; van den Brink MRM; Hanash AM
Blood; 2017 Aug; 130(7):933-942. PubMed ID: 28607133
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution following hematopoietic stem-cell transplantation.
Novitzky N; Davison GM
Cytotherapy; 2001; 3(3):211-20. PubMed ID: 12171728
[TBL] [Abstract][Full Text] [Related]
9. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
10. The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation.
Olkinuora H; von Willebrand E; Kantele JM; Vainio O; Talvensaari K; Saarinen-Pihkala U; Siitonen S; Vettenranta K
Scand J Immunol; 2011 Jun; 73(6):586-93. PubMed ID: 21323694
[TBL] [Abstract][Full Text] [Related]
11. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation.
Seggewiss R; Einsele H
Semin Hematol; 2007 Jul; 44(3):203-11. PubMed ID: 17631184
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic Effects of Rabbit Anti-thymocyte Globulin Preparations on Primary Human Thymic Epithelial Cells.
Kaebisch EM; Cho MY; Oh YS; Olfe LI; Szyska M; Becker SC; Reinke P; Volk HD; Gillissen B; Bullinger L; Thiel A; Na IK
Transplantation; 2019 Nov; 103(11):2234-2244. PubMed ID: 31205263
[TBL] [Abstract][Full Text] [Related]
14. Association between thymic function and allogeneic hematopoietic stem cell transplantation outcome: results of a pediatric study.
Saglio F; Cena S; Berger M; Quarello P; Boccasavia V; Ferrando F; Pittana L; Bruno B; Fagioli F
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1099-105. PubMed ID: 25708218
[TBL] [Abstract][Full Text] [Related]
15. Key players for T-cell regeneration.
Awong G; LaMotte-Mohs R; Zúñiga-Pflücker JC
Curr Opin Hematol; 2010 Jul; 17(4):327-32. PubMed ID: 20571395
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
17. [Alloreactive donor lymphocytes (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT): study of toxicity and efficacy].
Michallet AS; Nicolini F; Michallet M
Bull Cancer; 2003; 90(8-9):758-62. PubMed ID: 14609766
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic transplantation for myelodysplastic syndrome (MDS).
Ingram W; Lim ZY; Mufti GJ
Blood Rev; 2007 Mar; 21(2):61-71. PubMed ID: 16759774
[TBL] [Abstract][Full Text] [Related]
19. Keratinocyte growth factor and stem cell factor to improve thymopoiesis after autologous CD34+ cell transplantation in rhesus macaques.
Wils EJ; Aerts-Kaya FS; Rombouts EJ; van Mourik I; Rijken-Schelen A; Visser TP; Braakman E; Wagemaker G; Cornelissen JJ
Biol Blood Marrow Transplant; 2012 Jan; 18(1):55-65. PubMed ID: 21963880
[TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution after haematopoietic stem cell transplantation: obstacles and anticipated progress.
Cavazzana-Calvo M; André-Schmutz I; Dal Cortivo L; Neven B; Hacein-Bey-Abina S; Fischer A
Curr Opin Immunol; 2009 Oct; 21(5):544-8. PubMed ID: 19766472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
